- $58.35bn
- $57.34bn
- $2.31bn
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. Supreme Court rejects CareDx appeal in Natera false-advertising dispute (updated)
Corrected: U.S. Supreme Court rejects CareDx appeal in Natera false-advertising dispute
U.S. Supreme Court rejects Natera, CareDx false-advertising dispute
Brief: EXPAND Expand Trial Of Natera's Fetal Focus Single-Gene Nipt Surpasses >2,000 Patients Enrolled
Judge sanctions law firm Quinn Emanuel, citing ethical lapses
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson
Natera beats Q1 revenue estimates, lifts annual outlook
Brief: Natera Q1 EPS USD -0.6
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE -Gyre Therapeutics, Nutrien Ltd, Rapid Micro Biosystems
U.S. STOCKS ON THE MOVE -Natera, Pacira BioSciences, Kezar Life Sciences
U.S. STOCKS ON THE MOVE-SciSparc, Natera, US energy companies
Natera rises after launching new genetic test for rare diseases
Gene testing firm Natera's Q4 revenue rises 39.8%
Brief: Natera Q4 Operating Expenses USD 466.5 Million
Brief: Successful Readout Of Prospective Phase 2 Sinergy Trial Supports Signateratm Mrd-Guided Treatment
Brief: Natera Submits Signatera™ CDx PMA To FDA
Brief: Natera To Scale AI Foundation Models In Precision Medicine With Nvidia